Novartis | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 327.88B 42.76B 2025-06
Amgen USD 150.13B 17.37B 2025-06
AstraZeneca GBP 215.51B 41B 2025-06
Bausch Health Companies CAD 3.36B 87.55M 2025-06
Biogen USD 18.41B 1.62B 2025-06
Bristol-Myers Squibb USD 94.2B 29.9B 2025-06
Canopy Growth CAD 225.05M 88.93M 2025-09
Corcept Therapeutics USD 7.78B 4.27B 2025-06
Drreddys Laboratories USD 2.37B 10.15B 2025-09
Eli Lilly USD 738.79B 2.87B 2025-06
Gilead Sciences USD 137.91B 1.77B 2025-06
GlaxoSmithKline GBP 56.24B 4.11B 2025-06
Glaxosmithkline USD 82.21B 2.63B 2025-09
J&J USD 366.71B 32.94B 2025-06
Merck USD 198.77B 27.1B 2025-06
Novartis CHF 256.18B 64.49B 2025-06
Novartis USD 258.67B 24.42B 2025-09
Pacira USD 1.11B 43M 2025-06
Perrigo USD 3.65B 177M 2025-06
Pfizer USD 137.53B 6.19B 2025-06
Prestige Brands USD 3.93B 325M 2025-06
Sanofi EUR 100.06B 25.78B 2025-06
Sanofi USD 125.19B 7.59B 2025-09
Supernus Pharmaceuticals USD 1.76B 65M 2025-06
Zoetis USD 69.43B 4.01B 2025-06


Novartis Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.